Thursday, July 10, 2025
HomeTagsNews

news

Hemab Therapeutics Announces First Drug Candidate: HMB-001

Hemab Therapeutics, a biotechnology company developing next-generation therapeutics for serious, underserved bleeding and thrombosis disorders, unveiled its lead candidate, HMB-001, a novel bispecific antibody...

Genesis MedTech Acquires JC Medical, Creates New Structural Heart Franchise

Genesis MedTech Group (Genesis or Group) has completed the acquisition of JC Medical (JCM), a structural heart company that is primarily engaged in the...

Final Analysis of Pivotal HOPE-B Study Demonstrates Durable and Sustained Therapeutic Effect of Etranacogene Dezaparvovec Gene Therapy

Global biotherapeutics leader CSL Behring announced positive long-term results from the Phase 3 HOPE-B clinical trial evaluating etranacogene dezaparvovec (EtranaDez), an investigational adeno-associated virus...

BioMarin Announces Oral Presentation of 2-Year Analysis of Largest Phase 3 Gene Therapy Study in Adults

BioMarin Pharmaceutical Inc. announced that the Company presented positive results from a two-year analysis of the Phase 3 GENEr8-1 study and an overall safety...

Truwl Releases Free Benchmarking Tool for Genomics

Truwl , a Montana-based bioinformatics company, announced that it is releasing a free version of its germline variant-calling benchmarking workflow to remove cost as...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics